MEDIMMUNE, LLC. for MEDIMMUNE LLC
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report | Jan 19, 2012 | $370,000 | Replaced |
| 4th Quarter - Amendment (this page) | Apr 19, 2012 | $580,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
HR 2055/Pub. L. No. 112-74 - Consolidated Appropriations Act, 2012, provisions relating to funding for Health and Human Services Issues related to CDC Burden of Disease Study on Respiratory Syncytial Virus (RSV), including RSV prophylaxis; vaccine and related services reimbursement; Medicaid reimbursement; health reform implementation; biologics data exclusivity; and, debt and deficit reduction proposals on Medicaid federal funding, Medicaid rebates, and Medicare Part D rebates
Foreign entity interest: As the ultimate parent of MedImmune, LLC, AstraZeneca PLC has interests in the issues lobbied.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAUREN RANDALL BUCKLEY | — |
| VANESSA PROCTER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.